Breastfeeding reduces type 2 diabetes risk by boosting beta cells.

Insulin-producing cells grown in the lab could offer a functional cure for the disease.

The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.

Researchers used a trio of transcription factors to transform pancreatic duct cells in vivo into β-like cells that secrete insulin and improve diabetes symptoms.

Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.

A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.

Scientists have constructed three-dimensional maps depicting the size and location of insulin-producing islet cells in the mouse pancreas.

The diabetic volunteer continued to produce insulin one year after she received a transplant of abdominal islet cells.

The results, which could not be replicated, suggested that a hormone increased pancreatic β cell proliferation, supplanting insulin as a front-line diabetes treatment in mice.